Novo Nordisk builds AI drug discovery platform on Azure with Microsoft Research
Novo Nordisk · Denmark
Novo Nordisk partnered with Microsoft Research to build an AI platform on Azure AI and data stacks spanning regulatory affairs, early research, drug discovery and trial design, using Azure OpenAI Service, Azure Cosmos DB and Azure Kubernetes Service, with Power BI and Power Apps for collaboration. The platform includes a copilot for researchers, shared reasoning-chain templates, and governance/auditing of how data and models are used. The teams published early results on predictive AI models for cardiovascular disease risk detection, including an algorithm that Novo Nordisk says predicts patients' cardiovascular risk better than the best clinical standards, drawing on more than 100 years of insulin research data.
Overview
Novo Nordisk partnered with Microsoft Research to build an AI platform on Azure AI and data stacks spanning regulatory affairs, early research, drug discovery and trial design, using Azure OpenAI Service, Azure Cosmos DB and Azure Kubernetes Service, with Power BI and Power Apps for collaboration. The platform includes a copilot for researchers, shared reasoning-chain templates, and governance/auditing of how data and models are used. The teams published early results on predictive AI models for cardiovascular disease risk detection, including an algorithm that Novo Nordisk says predicts patients' cardiovascular risk better than the best clinical standards, drawing on more than 100 years of insulin research data.
This entry has 12 published fields tied to exact passages in an immutable source capture.
Inspect the highlighted sourceThe challenge
Developing high-quality medicine is a resource-intensive endeavor that requires collaboration across Novo Nordisk. Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning.
The solution
In partnership with Microsoft Research, Novo Nordisk built an AI platform on Azure AI and data stacks spanning regulatory affairs, early research, drug discovery and trial design. The platform combines unification (a single place to discover data and models), a copilot tool for researchers to reason with data and AI, shared reasoning-chain templates for collaboration, and governance auditing of how data and models are used. Microsoft Azure OpenAI Service is used alongside Azure Cosmos DB and Azure Kubernetes Service (AKS), with Power BI and Power Apps for collaboration.
Reported business value
The teams recently published early results from predictive AI models for advanced risk detection in cardiovascular diseases, including an algorithm that, according to Novo Nordisk's Senior Vice President of Digital Science and Innovation, can predict patients' cardiovascular risk better than the best clinical standards.
Sources
Open any source and check the claim yourself — that is the point of the register.
Other healthcare entries in the register.
CDPHP modernizes infrastructure and improves medical data extraction with AWS AI/ML
CDPHP, a not-for-profit health plan serving 400,000 members in Upstate New York, used AWS services including Amazon Comprehend Medical, Amazon Textract, and Amazon SageMaker to automate its data processing pipeline for unstructured medical records and health data. The organization processed over seven million records during initial migration and now processes 3,000 electronic health records weekly. CDPHP achieved a 60% improvement in overall efficiency and reduced HEDIS report generation from 4-5 days (three data scientists) to two reports produced daily.
Mayo Clinic deploys NVIDIA DGX SuperPOD to accelerate pathology foundation models
Mayo Clinic deployed an NVIDIA DGX SuperPOD with NVIDIA DGX B200 systems to support foundation model development for pathomics, drug discovery and precision medicine. In partnership with Aignostics, Mayo Clinic built the Atlas pathology foundation model, trained on more than 1.2 million histopathology whole-slide images. The new infrastructure is reducing four weeks of pathology slide analysis work to one week.
Myriad Genetics speeds document processing with AWS GenAI Intelligent Document Processing Accelerator
Myriad Genetics partnered with the AWS Generative AI Innovation Center to replace an Amazon Textract/Comprehend pipeline with Amazon Bedrock foundation models (Nova Pro for classification, Nova Premier for extraction) using the open-source GenAI IDP Accelerator. Document classification accuracy rose from 94% to 98%, classification cost per page fell 77% (3.1 cents to 0.7 cents), and classification time fell 80% (8.5 minutes to 1.5 minutes per document). Automated key information extraction reached 90% accuracy matching the manual baseline, with a projected $132K in annual savings and 300 hours saved monthly across 9,000 prior authorizations in the Women's Health unit alone.
Forcura Expedites Patient Care Using Generative AI on Amazon Bedrock
Forcura, a HITRUST-certified healthcare workflow management company serving over 900 healthcare providers representing about 1 million patients, added a generative-AI referral summary feature to its Referral Management product. Built on Amazon Bedrock using Anthropic's Claude 3 model family, the feature pulls key information such as patient demographics, clinical history and requested services into a concise summary. Forcura piloted the feature with three clients in April 2024 and reached general release within 90 days of the pilot start.
Was this helpful?
Your feedback helps us improve our use case database